Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,911,978
-$257,938 QoQ
Shares Held
11,572
-20.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#1,671
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Global Investments holds $32,800,954 across 11 Drug Manufacturers - General names. ABBV ranks #3 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,407 | $12,482,469 | |
| 2 | MRK |
Merck & Co., Inc.
|
52,039 | $6,687,011 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
11,572 | $2,911,978 | |
| 4 | JNJ |
Johnson & Johnson
|
9,808 | $2,490,937 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
11,712 | $1,479,694 | |
| 6 | PFE |
Pfizer Inc
|
60,517 | $1,457,249 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
23,680 | $1,364,441 | |
| 8 | AZN |
Astrazeneca PLC
|
6,543 | $1,240,683 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,911,978 | 11,572 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,169,916 | 14,575 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $3,865,136 | 16,916 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $3,225,120 | 13,929 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,638,402 | 14,214 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $687,016 | 3,279 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $2,357,190 | 13,265 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,299,852 | 11,646 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,208,834 | 12,878 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $2,753,534 | 15,121 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $8,996,938 | 58,056 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,627,189 | 64,586 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $8,514,531 | 63,197 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $2,792,162 | 17,520 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $9,334,593 | 57,760 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $7,897,184 | 58,842 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,972,572 | 58,583 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $19,907,918 | 122,805 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $5,852,123 | 43,221 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,003,163 | 37,111 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $4,455,362 | 39,554 | Shares | Sole | 2022-01-28 | |
| 2021-03-31 | $4,385,182 | 40,521 | Shares | Sole | 2022-01-27 | |
| 2020-12-31 | $4,289,750 | 40,035 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,945,213 | 33,625 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,438,459 | 35,022 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,489,819 | 19,554 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||